CL
Covariance Labs Inc.
SEC filingOther Technology · New York, NY
Amount raised$11Msold at filing
Total offering$11M
Investors in the raise6count reported to the SEC
FiledMar 9, 2026first sale Jan 15, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Thomas JermolukDirector
Michael FlederExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.